Semax is a synthetic peptide derived from the adrenocorticotropic hormone (ACTH) fragment (Met-Glu-His-Phe-Pro-Gly-Pro). Originally developed and prescribed in Russia, Semax has been widely studied for its potential nootropic, neuroprotective, and neurorestorative properties.

Benefits (Research Focus)

• Melanocortin receptor pharmacology — studied for MC3R, MC4R, and MC5R receptor binding activity as an ACTH-derived peptide

• BDNF pathway research — investigated for hippocampal BDNF gene expression endpoints in rodent research models

• Transcriptomic research — explored for gene expression panel effects in CNS cell research models

• Peptide pharmacology research — examined for receptor binding profiles and SAR studies of ACTH-derived heptapeptides

• Comparative SAR research — researched alongside N-Acetyl Semax for comparative N-terminal modification studies

⚠️ Disclaimer

• This product is intended for laboratory research use only.
• Not for human or veterinary use.
• Not approved for diagnostic, therapeutic, or medical applications.
• Handle using appropriate laboratory safety procedures and personal protective equipment.